Akers Biosciences (AKER) Reports Q2 Loss of $0.41/Share

Akers Biosciences (NASDAQ: AKER) reported Q2 EPS of ($0.41), versus ($0.10) reported last year. Revenue for the quarter came in at $966.9 thousand, versus $1.35 million reported last year.

For earnings history and earnings-related data on Akers Biosciences (AKER) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c